Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center.

D. Spyratos (Thessaloniki, Greece), I. Tsiouprou (Thessaloniki, Greece), V. Tsartsianidou (Thessaloniki, Greece), S. Lampaki (Thessaloniki, Greece), E. Eleftheriadou (Thessaloniki, Greece), K. Domvri (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece)

Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Session: Thoracic oncology: Treatment, diagnostic options and biology
Session type: Thematic Poster
Number: 4678

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Spyratos (Thessaloniki, Greece), I. Tsiouprou (Thessaloniki, Greece), V. Tsartsianidou (Thessaloniki, Greece), S. Lampaki (Thessaloniki, Greece), E. Eleftheriadou (Thessaloniki, Greece), K. Domvri (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece). Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center.. 4678

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: